2 terminated, 1 active not recruiting, 1 completed, 1 recruiting. 4 Not applicable, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Active not recruiting 1, Recruiting 1, Terminated 1, Withdrawn 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Stage IV Vulvar Cancer AJCC v8: new trials by email Literature Review of Stage IV Vulvar Cancer AJCC v8 trials Research Report on Stage IV Vulvar Cancer AJCC v8
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer Best Practice, Interview, Supportive Care - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | Not applicable | Recruiting | City of Hope Medical Center | 126 | 2026-09-09 | 2026-10-16 |
| Virtual Mental Health Intervention to Address Fear of Progression for Women With High Risk or Stage III-IV Gynecologic or Breast Cancer Behavioral Intervention, Educational Intervention, Internet-Based Intervention - Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8 | Not applicable | Withdrawn | City of Hope Medical Center | 2026-07-16 | 2026-02-04 | |
| e-Health Intervention (Day-by-Day) for the Management of Fear of Progression in Women With Stage III or IV Gynecologic Cancer: A Pilot Study Discussion, Informational Intervention, Media Intervention - Malignant Female Reproductive System Neoplasm, Stage III Cervical Cancer AJCC v8 | Not applicable | Active not recruiting | City of Hope Medical Center | 23 | 2024-07-19 | 2026-01-28 |
| Paclitaxel Therapeutic Drug Monitoring in Cancer Patients Blood draws, QLQ-CIPN20 Survey, PR-CTCAE Survey - Solid Tumor, Adult, Metastatic Nonsmall Cell Lung Cancer | Suspended | Wake Forest University Health Sciences | 55 | 2019-11-11 | 2026-08-13 | |
| DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating Patients With Recurrent or Metastatic Human Papillomavirus Associated Cancers DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine MEDI0457, Durvalumab - Human Papillomavirus-16 Positive, Human Papillomavirus-18 Positive | Phase 2 | Terminated | M.D. Anderson Cancer Center | 41 | 2018-11-14 | 2024-07-09 |
| Stereotactic Body Radiation Therapy, Tremelimumab and Durvalumab in Treating Participants With Recurrent or Metastatic Cervical, Vaginal, or Vulvar Cancers Durvalumab, Laboratory Biomarker Analysis, Stereotactic Radiosurgery - Advanced Cervical Adenocarcinoma, Advanced Vaginal Carcinoma | Phase 1 | Completed | M.D. Anderson Cancer Center | 20 | 2018-07-18 | 2023-09-13 |
| Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervical, Vaginal and Vulvar Dysplasia and Cancer Biospecimen Collection, Laboratory Biomarker Analysis - Cervical Adenocarcinoma, Cervical Adenocarcinoma In Situ | Not applicable | Terminated | M.D. Anderson Cancer Center | 409 | 2014-10-27 | 2025-07-14 |
Vulvar Neoplasms (7) · Uterine Cervical Neoplasms (6) · Vaginal Neoplasms (6) · Ovarian Neoplasms (4) · Breast Neoplasms (2) · Endometrial Neoplasms (2) · Triple Negative Breast Neoplasms (2) · Anal Canal Carcinoma (1) · Anus Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1) · Genital Neoplasms, Female (1) · Lung Neoplasms (1) · Neoplasm Metastasis (1) · Neoplasms (1) · Penile Neoplasms (1)
Female Urogenital Diseases (7) · Female Urogenital Diseases and Pregnancy Complications (7) · Genital Diseases (7) · Genital Diseases, Female (7) · Neoplasms by Site (7) · Urogenital Diseases (7) · Urogenital Neoplasms (7) · Uterine Diseases (7) · Vulvar Diseases (7) · Genital Neoplasms, Female (6) · Neoplasms (6) · Uterine Cervical Diseases (6) · Uterine Neoplasms (6) · Vaginal Diseases (6) · Adnexal Diseases (4)
Disulfides (2) · Immunoglobulin G (2) · Interviews as Topic (2) · durvalumab (2) · Behavior Therapy (1) · Blood Specimen Collection (1) · Early Intervention, Educational (1) · Educational Status (1) · MEDI0457 (1) · Methods (1) · Palliative Care (1) · Practice Guidelines as Topic (1) · Radiosurgery (1) · Standard of Care (1) · VGX-3100 (1)
City of Hope Medical Center (3) · M.D. Anderson Cancer Center (3) · Wake Forest University Health Sciences (1)
United States (7)
Anne Reb (3) · Kathleen Schmeler (1) · Lilie L Lin (1) · Michael M Frumovitz (1) · Roy Strowd, MD (1)
P30CA033572 (3), R21CA293326 (2), P30CA012197 (1)